TX-MARY-KAY
21.11.2023 18:04:33 CET | Business Wire | Press release
Mary Kay Inc., a global beauty brand and advocate for women’s empowerment, is excited to announce its membership in the Global Shea Alliance (GSA), a non-profit industry association that designs, develops and delivers strategies that drive a competitive and sustainable shea industry worldwide. This new partnership aligns with Mary Kay's commitment to sustainability and its mission to empower women around the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231121605161/en/
“This partnership marks a significant step in our journey to promote sustainable beauty practices. By collaborating with the Global Shea Alliance, we aim to further harness the transformative potential of shea in skincare and cosmetics," said Deborah Gibbins, Chief Operating Officer at Mary Kay. (Credit: Mary Kay Inc.).
The GSA's core values are founded on promoting an inclusive value chain, fostering a pre-competitive and business-driven industry by ensuring sustainability and maintaining confidentiality in all transactions with its stakeholders.
“We are absolutely thrilled to join the Global Shea Alliance,” said Deborah Gibbins, Chief Operating Officer at Mary Kay. “This partnership marks a significant step in our journey to promote sustainable beauty practices. By collaborating with the GSA, we aim to further harness the transformative potential of shea in skincare and cosmetics.”
Mamatou Djaffo, President of the Global Shea Alliance, expressed her enthusiasm about the new partnership. “We extend a heartfelt welcome to Mary Kay Inc,” said Mamatou Djaffo. “Their stellar reputation as champions of corporate social responsibility and sustainability perfectly aligns with our mission. We are thrilled at the prospect of collaborating with Mary Kay to drive substantial positive change within the cosmetics industry. Together, we aim to establish new industry standards for social and environmental responsibility, transcending beauty to empower individuals, promote sustainability, and foster a more resilient future for the millions of women who depend on shea.”
This exciting partnership between Mary Kay Inc. and the Global Shea Alliance in the upcoming year will spearhead initiatives aimed at enhancing the economic well-being of shea collectors and processors, as well as undertaking crucial efforts to restore degraded parklands in West Africa.
Earlier this month, Mary Kay hosted Aaron Adu, GSA Managing Director, and Olawunmi Osholake, GSA Deputy Managing Director, at its manufacturing facility, the Richard R. Rogers (R3) Manufacturing / R&D Center in Lewisville, Texas, U.S.A. for a site visit followed by a meeting exploring synergies and engagement opportunities.
About Mary Kay
Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram and LinkedIn, or follow us on X (formerly known as Twitter).
About Global Shea Alliance
The GSA is a non-profit industry association with 919 members from 39 countries including women collectors and processors, brands and retailers, ingredient suppliers, civil society, research institutions and policymakers. Through public-private partnerships, the GSA promotes industry sustainability, quality practices and standards and demand for shea in food and cosmetics. For more information, please visit https://globalshea.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231121605161/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom